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Abstract
Quantum dots are semiconductor fluorescent nanocrystals that exhibit excellent character-
istics compared with more commonly used organic fluorescent dyes. For many years quan-
tum dot conjugated products have been available in multiple forms for fluorescence
imaging of tissue sections under the trademark name Qdot®. They have much increased
brightness, narrow emission spectrum, large Stokes shift and photostability compared with
conventional organic fluorescent dyes, which together make them the fluorophores of
choice for demanding requirements. Vivid Qdots are recent replacements for original
Qdots, modified to improve brightness, however this has affected the fluorescence stability
in commonly used conditions for immunohistochemistry. We present here our investigation
of the stability of original and Vivid Qdots in solution and in immunohistochemistry, highlight
the potential pitfalls and propose a protocol for stable and reliable multiplex staining with
current commercially available original and Vivid Qdots.
Introduction
Quantum dots (Q-dots) are semiconductor fluorescent nanocrystalswith important advan-
tages as fluorophores compared with commonly used organic fluorescent dyes. Their broad
excitation spectra, narrow and symmetrical emission spectra and large Stokes shifts permit
more accurate quantification without interchannel bleed through. Q-dots also have excellent
fluorescence efficiency:high molar extinction coefficients and quantum yields up to 90% pro-
vide a fluorescence output (brightness of emission) many times greater than conventional dyes.
In addition, a long excitation state (10-40ns) and photostability about 1000-fold that of con-
ventional organic fluorescent dyes make Q-dots ideally suited for fluorescence image capture
and quantification (for reviews [1, 2]).
Taken together, these advantages make Q-dots the fluorophores of choice in demanding
fluorescence imaging settings. In particular, for multiplex immunofluorescence staining of
PLOS ONE | DOI:10.1371/journal.pone.0163856 September 29, 2016 1 / 23
a11111
OPENACCESS
Citation: Prost S, Kishen REB, Kluth DC, Bellamy
COC (2016) Working with Commercially Available
Quantum Dots for Immunofluorescence on Tissue
Sections. PLoS ONE 11(9): e0163856.
doi:10.1371/journal.pone.0163856
Editor: Makoto Kanzaki, Tohoku University, JAPAN
Received: April 21, 2016
Accepted: September 15, 2016
Published: September 29, 2016
Copyright: © 2016 Prost et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All data are within the
paper and its Supporting Information files.
Funding: The work was supported by a project
grant from the CSO (Chief Scientist Office
Scotland, http://www.cso.scot.nhs.uk/) EMT/189 to
DK, CB, and SP, a Moray Endowment Fund award
to SP (University of Edinburgh, http://www.ed.ac.
uk)), and an Innovation grant (GR01858) from the
University of Edinburgh Development Trust. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
tissue sections, they ameliorate the key confounders of low signal/noise ratio and crossover
from incompletely filtered overlap between conventional fluorophore emission spectra. Their
use with spectral imaging analysis also allows accurate determination of false signal arising
from antibody cross-binding.
For immunofluorescence,most investigators purchase commercially available Q-dots (tra-
dename Qdot1 for InVitrogen and referred as Qdot), which are available in different forms,
including as conjugates with antibody, with streptavidin, or in kits to complex Qdots to an anti-
body of choice (InVitrogen—Molecular Probes). Commercial, 1st generation Qdots (InVitro-
gen) applied to tissue sections have been found to be stable by ourselves (Qdots 525, 565, 585,
605, 655, and 705 in Qmount medium and others [3]) with no loss of fluorescence over 3 years
after initial staining (Fig 1).
From 2012 and beginningwith Qdots 625, original Qdots were sequentially replaced with
Qdots made using the Vivid technology (Vivid Qdots), although retaining the original name
and catalogue number until recently (Table 1). Vivid Qdots had an undisclosedmodification
of the core/shell manufacture and specific details of the chemical differences of Vivid Qdots
from original Qdots have not been released, but they exhibit an improved extinction coefficient
[4] (S1 Fig). However, in our hands, Vivid Qdots were less stable than the original Qdots,
showing fading, photobleaching and quenching when used according to recommended
protocols.
We report here evaluations of the stability and quenching of original and Vivid Qdots in
various mounting media, different buffers routinely used in immunochemistry, as well as long
term stability. We propose a protocol to maximise stability, and suggest specific controls that
allow investigators to confirm the reliability of multiplexing studies performedwith the cur-
rently available commercial Qdots.
Material and Methods
Image capture & analysis
For all comparisons, serial sections were stained with the indicated method and the similar
serial fields were imaged at indicated times, and under indicated conditions. All pictures were
taken using a spectral camera with tunable filter (Nuance FX; Perkin Elmer) and illumination
with a LED at 425nm (Cool-LEDPE-2) or 435nm (Cool-LEDPE-1000). LED illumination of
Qdots was chosen for even, stable illumination without photobleaching of original Qdots [5].
Quantification of the intensity of fluorescencewas performed using the Nuance software,
with either autothreshold when different slides were compared or selection of region of interest
(ROI) through automatic or manual thresholding and use of the same region to analyse the
exact same areas when a time course of the fluorescence intensity was performed (slide kept on
microscope stage during the whole of the experiment) or using AxioVision (Zeiss) software.
Immunostaining
Preparation of tissue and general information. All stainings were performed on human
inflamed liver or kidney tissue. The sections were deparaffinized in xylene (2x 5 min) followed
by rehydration through ethanol solutions and 2 minutes wash in tap water. Antigen retrieval
was performed in boiling 0.1mMEDTA pH8.0 in a pressure cooker at pressure for 12 minutes.
All antibodies (Ab) and streptavidin Qdots were freshly diluted in Bond diluent (Leica,
AR9352) at the appropriate concentrations. A list of the antibodies and concentrations used as
well as short hand protocols are available in S1 File.
Immunostaining with streptavidin conjugated Qdots (protocol established for the first
generation Qdots). Single staining (short protocol 1 in S1 File): After antigen retrieval, the
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slides were rinsedwith BondWash (Leica, AR9590) for 5 minutes, endogenous biotin was
blocked using Avidin/Biotin blocking kit (ABBK) as recommended by the manufacturer (Vec-
tor SP-2001).
Slides were incubated with the indicated primary antibody for one hour at room tempera-
ture, washed in BondWash (Leica, AR9590) for 5 minutes and incubated with the appropriate
biotinylated secondary antibody (Dako) for 30 minutes at room temperature. After a wash
with BondWash the slides were incubated for one hour with the streptavidin Qdot. The slides
were then counterstained and mounted (see below).
Fig 1. Stability of 5 color immunofluorescence performed with original Qdots: TNFα 525 (yellow), CCR2 605 (green), MHCII 655 (purple), CD68
705 (red) & Qnuclear red (blue), mounted in Qmount and captured 27 months apart. A: unmixed images for each fluorophore and combined 5-colour
images at the time of staining (t1) and 27 months later (t2). The cubes were captured (500nm to 720 nm) and unmixed using Nuance. The images shown
are false colour images viewed with Clip/Stretch; mapping the lowest 0.01% of the pixels to 0, the highest 0.01% to 255, and linearly interpolating in
between. The contrast has been increased 14% in all the photos for more representative printing. No other alterations were performed. The intensity of
fluorescence of positive cells for each marker was analysed with the Nuance software and compared between the 2 time points. There was no significant
difference in the fluorescence intensity of any marker photographed 27 months apart (p = 0.223, ANOVA). B: Box plot of the mean fluorescence intensity
of each fluorophore in the cells of interest (ie thresholded for positivity with the marker labelled by Qdot 525) on the initial image (t1) and after 27 months
(t2).
doi:10.1371/journal.pone.0163856.g001
Table 1. Dates of reception of Vivid Qdots & lot number.
Qdot Streptavidin Qdots First built Qdot conjugated secondary Ab First built
525 original na original na
565 original na original na
585V Dec-13 1344947 Apr-13 Mar-14 1499312 Jan-14 (DαM) Aug-13 (DαR)
605 Apr-13 1259352 Jun-12 Mar-14 1567298 & 1537322 Jun-13 (DαM) Oct-12 (DαR)
625V Unknown * Unknown * Apr-14 1562999 Unknown *
655V Nov- 12 1144689 Apr-12 Apr-14 1378332 Dec-11 (GαM) Nov-12 (DαG) Nov-12 (DαR) Aug-12 (DαM)
705V Nov-12 1138561 Feb-12 Mar-14 1370933 Aug-12 (GαM) Apr-3 (GαR)
*Date of first use is unknown as initial Qdot625 were not labelled as “Vivid” but were always Vivid technology (InVitrogen personal communication). First
build dates were provided by the technical services from Life Technology in March 2016.
DαM: donkey anti-mouse; DαR: donkey anti-rabbit; GαM goat anti-mouse; GαR: goat anti-rabbit
doi:10.1371/journal.pone.0163856.t001
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Multiple immunostaining (example of 4 markers) (short protocol 2 in S1 File): After antigen
retrieval, the slides were rinsed with BondWash for 5 minutes, endogenous biotin blocked
(Vector SP-2001) and incubated with serum-free protein block (Dako, X0909) for 10 minutes,
prior to simultaneous incubation with primary Ab 1 & 2 (produced in different species) over-
night at 4°C. The next day, all remaining steps were performed at room temperature. After a
brief wash in BondWash the slides were incubated with the first biotinylated secondary anti-
body diluted in background reducing diluent BKRA (DAKO, S3022) with 1% serum for 30
minutes, washed and incubated with the first streptavidin Qdot. Spare streptavidin and biotin
sites were blocked using the ABBK (Vector SP-2001), followed by 10 min incubation in serum-
free block (Dako, X0909) and 30 min with the second secondary antibody diluted in BKRA.
The slides were then washed and incubated with the second streptavidin Qdot for 30 minutes.
A further treatment with serum-free protein block (Dako, X0909) was performed for 10 min-
utes prior to incubation with primary antibodies 3 & 4 for 1 hour at room temperature. The
slides were then washed in BondWash; incubated with the third secondary antibody diluted in
background reducing diluent BKRA (DAKO, S3022) with 1% serum for 30 minutes, washed
and incubated with the third streptavidin Qdot and this was repeated for the 4th primary and
secondaryAb. The slides were then counterstained and mounted (see below).
Mounting. After incubation with the last streptavidin Qdot the slides were washed in
BondWash and counterstained with Q-Nuclear Red (LifeTechnologies Q10363) diluted to 1 in
500 in 1x TBS for 5 minutes. After a few seconds rinse in water the slides were dehydrated
through 4 ethanol baths, cleared through 2 xylene baths and mounted in Qmount (InVitrogen
Q10336- discontinued).
Initial multiplex immunostaining with Qdots conjugated secondaryantibodies (short
protocol 3 in S1 File). All primary antibodies and streptavidin Qdots were diluted in Bond
diluent (Leica AR9352) and secondary antibodies were diluted in BKRA with 1% serum at the
appropriate concentration. All washes were performed in BondWash pH 7.5 (Leica, AR9590)
for 5 minutes unless specified.
The tissues were deparaffinized in xylene, followed by rehydration through ethanol solu-
tions and 2 minutes wash in tap water. Antigen retrieval was performed as described for stain-
ing with streptavidin Qdots. Slides were washed with and incubated with serum-free protein
block (Dako, X0909) for 10 minutes.
For single staining, slides were incubated with the primary antibody one hour at room tem-
perature. The slides were washed with BondWash for 5 min and incubated for 1 hour at room
temperature with the appropriate Qdot conjugated secondary antibody. For multiplex staining
the first primary Ab was applied overnight at 4°C. After a wash the slides were incubated with
the 1st Qdot conjugated secondary antibody for 30 min, washed and the appropriate Fab was
used to saturate the primary Ab (10 min). This was followed by a serum free protein block (10
min) prior to incubation with the next primary Ab. The staining steps were repeated for all pri-
mary antibodies. Note that for multiplex staining wash time is reduced to 3 minutes and sec-
ondary Ab incubation to 30 minutes. Once the staining completed, the slides were washed
once more in BondWash and counterstained with Q-Nuclear Red (LifeTechnologies Q10363)
diluted to 1 in 500 in TBS for 10 minutes rinsed briefly (few seconds) in tap water, dehydrated
through increasing concentrations of alcohol, cleared through xylene and mounted in Cytoseal
mountant (Richard-Allen Scientific 8310–4) or Ecomount (EM897L Biocare medical).
Final method for Qdot conjugated secondaries (and streptavidinQdot) (short protocol
4 in S1 File). All primary antibodies and streptavidin Qdots are diluted in BKRA and all sec-
ondary antibodies are diluted in BKRAwith 1% serum at the appropriate concentration.
All washes are done in BKRA wash (BKRA 1/50 in 50mMTris) for 3 minutes no more
unless specified.
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The tissue were deparaffinized, rehydrated and antigens retrieved as described above but
washed in TBS pH 8 for 5 minutes, (followed by incubation with Avidin/biotin block and wash
if a streptavidin Qdot staining will also be performed) then incubated with serum-free protein
block for 10 minutes (Dako, X0909).
The slides were incubated with the first primary antibody overnight at 4 degrees. All follow-
ing steps were performed at room temperature. The slides were washed and incubated with the
first Qdot-conjugated secondary antibody for 35 minutes. After a 3 minutes wash, the slides
were incubated with the appropriate FAB (Jackson Immuno, 715-007-003 or 711-007-003)
diluted at 1/25 or 1/50 (for αRabbit and αMouse respectively) in BKRA for 10 minutes fol-
lowed by a serum-free protein block (Dako, X0909) for 2x10 minutes.
The staining steps were repeated for all other markers (up to 6 color staining has been
tested) using the appropriate primary antibodies and Qdot-conjugated secondary antibody
(Ab) (35 minutes at room temperature for both.
If a streptavidin Qdot labelling was also required (requirement for an amplified signal) the
primary Ab incubation was followed by a wash in BKRA 1/50 in 50mM Tris for 3 minutes,
incubation with a specific biotinylated secondary antibody diluted in in BKRA with 1% serum
for 35 minutes, a further wash and incubation with the chosen streptavidin-conjugated Qdot
for 30 minutes.
After a wash the slides were counterstained with Q-Nuclear Red (LifeTechnologies Q10363)
diluted to 1 in 500 in BKRA for 5 minutes, rinsed briefly (few seconds) in BKRA 1/50 in 50mM
Tris, then dehydrated through increasing alcohol concentrations, cleared through xylene and
mounted in Ecomount mountant (Menarini DiagnosticsMP-EM897-100) and left at room
temperature in the dark overnight to set before imaging.
Fluorescence stability in solution in various buffers
All assays were done in duplicate in 96 well plates containing 100 μl of each Qdots at the appro-
priate concentration in the tested buffer (525 & 565: 1/200; 585 &605: 1/1000; 625, 655 & 705:
1/2000). Buffers tested include the following: PBS pH 7.5- Tris 50mM pH 7.5 containing or not
0.1%Tween; 1% PEG, 1%BSA—serum free protein block (Dako X0909)—BKRA (Dako S3022)
—TBS- Qdot diluent (2%BSA; 20mM borate buffer pH 8.3 containing 0.05% sodium azide)—
20mM borate buffer pH 8.3 containing or not 0.1% Tween. Once BKRAwas found to be pre-
venting quenching, we tested various dilutions of BKRA (1/2; 1/5; 1/10, 1/50) in 50mM Tris or
in “BondWash” containing or not 1% BSA. The excitation of the Qdots was done using illumi-
nation at 425 nm and the readings at 525, 565, 585, 615, 655 and 705 nm were done automati-
cally every 30 minutes for 5 to 15 hours.
Statistical analysis
Data were analysed using Minitab statistical software version 17. Comparisons for the effects of
the different factors (including categorical variables such as Qdots, buffers) on fluorescence
intensity data were made using Analysis of variance (ANOVA), General LinearModel. Where
indicated after fitting a general linear model, multiple comparisons between individual means
and factor levels were made with the control group using the Dunnett method with simulta-
neous 95% confidence intervals and adjusted p values, or pairwise comparisons using the
Tukey method and 95% confidence intervals, with adjusted p values. In some experiments a
2-sample t test was used to test for the difference between 2 samples, or, when involving
repeated measures of specific cells/microscopic fields, a paired t-test was used to test for differ-
ences between the paired observations.
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Tissue sourcing and ethical consent
The clinical tissue samples (inflamed human liver and kidney samples) used in this study were
surplus archival paraffin blockmaterial originally procured for diagnosis. The archival tissue
block samples were fully anonymised to the researchers and as such do not require patient con-
sent. Their use for this study was fully approved by the local clinical governance and ethics
committee (Lothian SAHSC and Tissue Governance Unit) with Approval Reference: 07/S1102/
21.
Results
Stability and quenching of original and Vivid Qdots in various mounting
media
OriginalQdots protocols fromMolecular Probes recommended that stained slides be mounted
in PBS or Qmount for viewing.However, after we reported to the company that illumination
of Original Qdots mounted in PBS led to quenching visible by eye (not shown), most protocols
were updated. Nevertheless, some sites continue to post out-dated protocols that recommend
PBS mountant [6].
PBS is still also often recommended as a wash buffer [4, 6–8], but this should avoided
whether using original or Vivid Qdots. Original Qdots are extremely stable in their dedicated
mounting mediumQmount (Fig 1) when no PBS buffer is used and we established a protocol
for 7 color immunofluorescence using Qdots 525, 565 or 585, 605, 625, 655, 705 and Qnuclear
red as nuclear counterstain (S1 File).
The introduction of new Vivid Qdots in our multiplex protocols led to unexpected results
that we eventually traced to the rapid fading of particularQdots. This was surprising given the
excellent and reliable results we had had previously. We compared the intensity of fluorescence
of single staining with streptavidin Qdots 525, 565, 585, 605, 655 and 705 from different
batches and eventually traced the problem to differences between original and Vivid Qdots. Fig
2 shows an example for Qdot 605: Vivid is about 3-fold brighter than the original Qdot with a
commensurate decrease of autoexposure time (91.86 & 46.54ms for original & Vivid Qdot
respectively). However continuous illumination for 2 minutes caused quenching of Vivid but
not the original Qdots, which reversed after 2 minutes without illumination (Fig 2). Similar
photo-quenching was observed for all other Vivid Qdots (examples of Qdot 655 & 585 shown
in Fig 3; average 41% and 57% intensity reduction by 300 seconds, respectively, p = 0.008, t
test). This instability made Vivid Qdots unsuitable for our quantification studies.
As Vivid but not original Qdots seemed affected we initially thought the mounting
medium could be the issue and compared the then recommendedQmount (2 batches) (inVi-
trogen/LifeTechnology Q10336) with Cytoseal60 (Thermo Fisher 8310–4) and Ecomount
(EM897L Biocare medical).Where still available, the original and Vivid Qdots were com-
pared. Striking differences in stability were found: original Qdots were very stable in Qmount
(Fig 4 and also Fig 1, after 27 months), but Vivid Qdots fluorescence decreased sharply with
excitation (average quenching in Qmount after 30 seconds illumination was 79% for Qdot
585Vivid (p<0.001; paired t-test), 52% for Qdot 655Vivid (p<0.001), compared with<1%
for Qdot 585). There was muted recovery during further constant illumination, and faster
recovery when the slides were left in the dark for 1 min (Fig 4). This quenching prevents reli-
able quantification. Fluorescence in Ecomount or Cytoseal seemedmore stable (Fig 4). Fol-
lowing our report to the company, Qmount was discontinued, however, care should be taken
with data obtained with Qdots staining in the past few years as people may not have been
aware of the issue.
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Long term stability in different mounting media
The fluorescencewas more stable in Cytoseal60 and Ecomount than in Qmount (Fig 4).
Because of the possibility of using other fluorophores alongside Qdots for greater than 6 colors
multiplexing, we tested the stability of Cy3, Cy5 and Alexa dyes 488 & 555 stains mounted in
Cytoseal and Ecomount (data not shown). We confirmed that Alexa dyes are stable in Cytoseal
[9] as are Cy3 and Cy5. Ecomount is reported to be inappropriate for Alexa(s) dyes (Ecomount
product sheet) and this was not tested further.
Although short term fluorescence of all Qdots mounted in Cytoseal or Ecomount then illu-
minated up to 5 minutes (Fig 4) was stable, we found that Vivid fluorescencewas more likely
to decrease within a few days after staining (Fig 5 & S2 File), especially in Cytoseal (S2 Fig).
Original Qdots in Cytoseal remained fairly stable up to 2 weeks after staining, but not for as
long as 49 days, unlike original Qdots in Qmount, which were stable for years (Fig 1). The
Vivid Qdots tended to fade more rapidly and to greater degree (Fig 5) (average 28% intensity
decrease across all Vivid Qdots in the initial 14 days versus 4% for original Qdots (p<0.001
ANOVA; average 44% decrease across all Vivid Qdots over all intervals to 609 days, compared
with 29% decrease for original Q dots; p<0.002). However, there was individual variations:
Qdot 705Vivid and 625Vivid were reproducibly more stable than the other Vivid Qdots, espe-
cially in kidney sections with the long term fading of Qdot 705Vivid being proportionately not
significantly worse than that of original Qdot 565 (p = 0.592, ANOVA). Qdot 585Vivid was the
least reliable in our hands.
Intriguingly, the decreased average and maximum fluorescencewas greater in the liver than
in the kidney sections (Fig 5 & S2 File) despite the mean areas thresholded being fairly constant
(S2 File). However, the mean area data should not be over-interpreted, as a minimum of 100
pixels (6.13μm2) is imposed during analysis, which might cause underestimation of any reduc-
tion of the area thresholded due to decrease in fluorescence (see S2 File).
Effect of common buffers used in immunostaining on Qdot fluorescence
With this in mind we tested the stability of the Qdots during 6 color multiplex
immunostaining.
Six color multiplex immunohistochemistry is typically performed over 2 days with the first
primary applied overnight. In these conditions, the first fluorophore is applied 9 to 10 hours
before the slide is mounted. We compared the fluorescence of each fluorophore done simulta-
neously as a single staining and as part of a multi-stain. The results were striking: all single
stains were bright, but in multiplex all the Vivid Qdots were quenching during the procedure
while original Qdots fluorescence looked stable (data not shown). Therefore in addition to pos-
sible quenching during visualisation and photobleaching once mounted, quenching was also
occurringduring the long staining protocol.
To confirm the quenching was due to the protocol time, we analysed the fluorescence levels
of the marker fluorophores (5 markers, 1 counterstain) after each staining round on 6 serial
Fig 2. Quenching of Vivid but not original Qdots under LED fluorescence illumination. FFPE serial liver sections were labelled for the
marker CD68 using a Labelled StrepAvidin Biotin (LSAB) method with either original streptavidin conjugated Qdot605 or streptavidin
conjugated Vivid Qdot605. Fig 2A shows the intensity of fluorescence for one representative cell stained with either the original Qdot (left) or the
Vivid Qdot (right): t0 represents the initial capture of the image; the sections were then left under constant illumination with LED 425nm for 2
minutes and finally left for a further 2 minutes in the dark. Note the difference in the intensity scale 0–5.95 for Original Qdot and 0–10.40 for
Vivid Qdot. Fig 2B: Intensity profile along the line drawn on each image. Line profiles were drawn on the initial images (t0) using the Nuance
software and copied onto the other images. For both original (left) and Vivid Qdot605 (right), the line profile intensities are given scaled to max
(red lines: initial intensity; green lines: after 2 minutes illumination with LED 325nm, blue after a further 2 minutes in the dark). The scale is given
by the lines which all are 13 μm in length.
doi:10.1371/journal.pone.0163856.g002
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sections stained in parallel (Fig 6). Addition of furthermultiplex markers (with additional
rounds of immunostaining) was associated with incremental reductions in brightness of the
index marker, which were pronounced for Qdots 605Vivid and 705Vivid, but minor for the
original Qdot 565 (Fig 6 & S3 Fig).
We therefore investigated which product in a standard immunofluorescencemay affect the
fluorescence of the Qdots. Protocol for Qdot staining recommends PBS as wash buffer [4, 7],
which we had replaced with “BondWash” (Leica, AR9590) as it did not lead to quenching of
the original Qdots unlike the recommended PBS. BondWash is a proprietary solution that
contains ProclinTM950, which we identifiedwith the Invitrogen team as a possible Qdot
quencher. We also tested a background reducing agent (BKRA) whose composition is not pro-
vided by the manufacturer. We tested the effect of those products as well as TBS as an alterna-
tive wash buffer on the intensity of Qdot 565 and Qdot 655Vivid fluorescence (Fig 7). After a
single staining round the fluorescence intensity of Qdot 655Vivid and Qdot585 did not vary
significantly between the different wash buffers (Fig 7A). Fluorescence after prompt mounting
also remained stable for at least 1270 minutes (Fig 7B), although the fluorescence intensity of
Qdot 655Vivid had reduced after mounting, compared with unmounted slides (Fig 7B)
(p<0.001, t-test). However, when the slides remained incubating in the buffers at room tem-
perature (for up to 330 minutes; Fig 7C) before mounting, there was an appreciable quenching
and photobleaching that varied according to both the Qdot and buffer (Fig 7C & 7D)(p<0.001
ANOVA). Qdot 565 was more stable than Qdot 655Vivid in all buffers, and Qdot 655Vivid in
BondWash or TBS soon became almost undetectable due to quenching and photobleaching
(Fig 7D). However, both the Vivid and original Qdots in BKRAwere significantly better pro-
tected from the loss of fluorescence compared with BondWash or TBS (p<0.001, ANOVA
with Tukey pairwise comparisons).
Six months after mounting, the fluorescence intensity of Qdot 565 left in BKRA for 1270
minutes was still similar to the original fluorescence level (0.033 +/- 0.001 counts/s for original
area at t0 vs 0.037 +/- 0.001 in both new area and original areas 6 months later). Qdot 565 left
in BondWash lost about half its intensity (0.036 +/-0.001 counts/s vs 0.018 +/- 0.000), while
that left in TBS showed no recognisable positive cells (only a few positive pixels remained). For
Qdot 655Vivid, fluorescencewas virtually undetectable when incubated in either BondWash
or TBS (only sparse positive pixels, but no identifiable positive cells). In the BKRA-incubated
slides, the Vivid fluorescencewas reduced to about one fifth in fields not previously imaged
(0.117 +/-0.005 to 0.022 +/-0.003 scaled counts/s). In areas previously imaged, the fluorescence
had gone almost completely, with no recognisable positive cells, so quantification was not
performed.
Taken together, these data show that significant photobleaching and quenching occur both
during the staining process and after mounting, particularly for Vivid Qdots, and that different
buffers affect the susceptibility of Qdots to these instabilities.
Given that our protocol respected pH and other conditions recommended [8, 10], we tested
the stability of all Qdots with time in each individual diluent and wash solution (Fig 8) using a
fluorimeter. We tested all Qdots in solution in Bond, PBS (recommended as wash buffer in
Fig 3. Photoquenching of Qdot 585Vivid and 655Vivid with exposure to LED 435nm. Serial sections of FFPE
tissue were stained for CD163 with Qdot 655Vivid (top panel) or Qdot 585Vivid (middle panel) and mounted in
Qmount. The stained slides were imaged at the indicated times during 30 minutes under continuous illumination,
then after “recovery” in the dark, every 2 minutes. A: The graphs show the decrease in mean (left) and maximum
(right) fluorescence intensity for Qdot 655Vivid (top panel) and Qdot 585 (middle panel) for four positive cells chosen
in the same field of view. B: The bottom graph shows the recovery of fluorescence in 2 representative positive cells
after the slides are kept in the dark for 2 minutes at a time.
doi:10.1371/journal.pone.0163856.g003
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Qdots immunostaining protocols), TBS, BKRA, borate buffer, Qdot diluent, borate & tween
buffer, serum free protein block, Tris, Tris tween, Tris PEG, Tris BSA for up to 1500 minutes.
We found that Qdots in solution faded progressively with time, to a variable degree that
depended on the diluent buffer (example plots for Qdot 525 & 655Vivid in Fig 8). All Qdots
were most stable in a proprietary background reducing agent, BKRA (Dako), which preserved
fluorescence intensity significantly better than any other buffer (adjusted p<0.001; ANOVA
with Tukey pairwise comparisons) with a mean relative intensity during the first 300 minutes
of 0.95 of the time zero value, compared with 0.72 for the next best buffer (SFB) and 0.33 or
less for buffers containing Tween (Fig 8). Indeed, Qdot 565 or Qdot 655Vivid in BKRA showed
no significant change in brightness with time (p = 0.157 and p = 0.586 respectively, ANOVA).
We were unable to obtain the exact composition of this buffer, but knowing that Qdots are
shipped in Borate buffer and that BKRA is a borate-based buffer at pH 8.35 we tested other
Fig 4. Different stability of Vivid (655 & 585) and original (585) Qdots on immunofluorescence slides
mounted in Qmount, Cytoseal and Ecomount. 16 serial sections of human inflamed liver were stained for
CD163 with original Qdot (585) or Vivid Qdots (585; 655 batch 1 or 655 batch 2) and imaged at the indicated
durations of continuous illumination with LED 435nm (t0 to 270 seconds), then left in the dark for 1 minute before
taking the last image. A: Graphs showing the average counts/s +/- SEM of positive regions of interest (ROIs)
thresholded on the image of one x40 field captured at t0 and used for analysis of all subsequent images. The
fields were matched in the serial sections. Asterisks indicate significant differences (* p<0.05; **p<0.01)
compared with the t0 control (black) or the t270 pre-recovery control (red) (ANOVA with Dunnett multiple
comparisons) B; representative images of cells labelled with Qdot 585 & Qdot 585Vivid at initial capture (t0), after
30 and 150 seconds illumination (30s LED & 150s LED) and after 270 second illumination followed by 60 second
recovery in the dark (270 LED +60s dark)
doi:10.1371/journal.pone.0163856.g004
Fig 5. Testing long term fluorescence stability in Cytoseal over 20 months. Serial sections of a block containing both liver and a
kidney were stained with the same primary Ab against CD163 and a secondary Ab directly conjugated with the indicated Qdot. The “same”
area was imaged at the indicated times after staining and intensity of fluorescence was obtained using Nuance software. A new area was
also imaged 609 days after initial staining (609n). The average fluorescence is shown, while Maximum fluorescence in thresholded positive
areas, Average and Total areas are available in S2 File together with representative images). Original Qdots (525& 565) were about one
tenth as bright as Vivid Qdots but their intensity remained fairly stable in both tissues for at least 14 days. Vivid Qdots photo-bleached
rapidly (see text). The difference of fluorescence intensity between liver and kidney sections stained with Qdot 585Vivid is partly due to the
choice of the kidney area captured, where the staining was particularly bright.
doi:10.1371/journal.pone.0163856.g005
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borate buffers, without reaching the stability provided by the BKRA.We repeated the test mul-
tiple times and confirmed that all Qdots, whether original or Vivid, are most stable in BKRA or
dilutions of BKRA in TRIS (Fig 8).
Fig 6. Decreased immunofluorescence during multiplex staining. Serial sections were stained with 1 to 5 different markers
(Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5,
CD68 streptavidin Qdot 525). After each staining round, a slide was mounted and imaged. Analysis of the intensity of Qdots 705Vivid,
605Vivid and 565 fluorescence is shown (Qdot 655Vivid & 525 in S3 Fig) for one representative field (aligned in serial sections). Each
dot corresponds to one thresholded positive cell. The intensity of fluorescence is affected by the number of staining rounds (p<0.001,
ANOVA) and the Qdot type (p<0.001, ANOVA): intensity decreases with the incremental number of subsequent staining rounds, and
the reduction is greater for Vivid than original Qdots, (fitted linear regression slopes for absolute and (in brackets) relative brightness
change with each additional staining round: -0.02 (-0.11) for Qdot 565; -0.22 (-0.23) for Qdot 605Vivid; -0.14 (-0.17) for Qdot 705Vivid).
B: representative images showing the fast decrease of Qdot 705Vivid intensity, and the lesser decrease of Qdot 565 with the number of
successive stainings. The Qdot 565 staining on slide 1–5 underwent the same treatments as Qdot 705Vivid on slide 1–3 ie 2 extra
rounds of staining. All 705 images are scaled 0–2.2 while 565 images are scaled 0–0.5 (according to the range of fluorescence intensity
after initial labelling with each Qdot).
doi:10.1371/journal.pone.0163856.g006
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Establishment of a reliable protocol for multiplexing with Qdots
A new protocol (S1 File) for multiplexing was tested using BKRA diluted 1/50 in TRIS for all
washes and mounting in Ecomount. This gave reliable results with stable fluorescence. This
protocol has now been usedmultiple times with 6-colour multiplex experiments using a com-
bination of 5 Qdots and Qnuclear red as nuclear counterstain, with reproducibly stable results
(Fig 9). In all multiplex staining, we now include tests for the stability of each Qdot over the
sequential staining steps, for the stability of each label with time in mountant, as well as the
usual controls for the antibody staining itself (Table 2).
Discussion
The present data show that recent alterations of the Qdots chemical structure to improve their
brightness have rendered the Qdots fluorescencemore sensitive to buffers and mounting
agents. Although the Vivid Qdots are much brighter than their original counterparts, we show
here that both photostability and long term stability are reduced in some conditions relevant to
immunofluorescence staining of tissue sections, including the initially recommendedmounting
medium in which photobleaching was observed. Fading is easily overlooked, for example, in
experiments using auto-thresholding, it could manifest as smaller areas selected leading to an
apparent unchanged mean of fluorescence. To prevent this pitfall, review of other parameters
(max & mean fluorescence) is recommended. Nevertheless, we have defined here conditions
and controls for reliable multiplex immunofluorescence with Qdots whereby photostability is
maintained, allowing their considerable advantages over other fluorophores to be realised.
Different types of quantum dots are classified according to their composition (for basic
information [11], for detailed information see [12]). The Qdots used in the present study are
described as core-shell Qdots, with a core of CdSe or CdTe, encapsulated in a shell of ZnS fur-
ther coated with a polymer and either streptavidin or Ab [13]. Coating quantum dots with
shells improves quantum yield through passivation [14] and can affect other photo-physical
properties [14–18] and many studies show how alteration of the surface coating alter various
characteristics such as solubility or toxicity (for reviews see [2, 19]).
Vivid Qdots have higher extinction coefficient and quantum yield (S1 Fig & LifeTechnol-
ogy, personal communication) leading to much increased brightness compared with the
Fig 7. Effect of different buffers and coverslip-mounting agents on fluorescence stability of Vivid
and original Qdots. Single MHCII immunofluorescence staining was done on 8 serial sections with either
Qdot 565 or Qdot 655Vivid conjugated secondary Ab. After staining, the sections were imaged in the wash
buffer used (A). Two control sections were then mounted in cytoseal (Qdot 655Vivid) or Qmount (Qdot 565)
and imaged regularly until the next day (B). The remaining slides were left in the indicated wash buffer and
imaged regularly for 5 1/2 hours (330 minutes); they were then coverslipped and imaged after mounting (380
minutes), as well as the next day (1270 minutes) (C & D). A: After a single staining round the fluorescence
intensity of Qdot 655Vivid and Qdot585 did not vary significantly between the different wash buffers. B: The
fluorescence intensity of Qdot 655Vivid mounted in Cytoseal and of Qdot 565 mounted in Qmount after a
staining protocol using Bond Wash remained stable in mountant for at least 1270 minutes (p = 0.599,
ANOVA), although the fluorescence intensity of Qdot 655Vivid had still reduced after mounting, compared
with unmounted slides (** p<0.001, t-test). C &D: Qdot 565 was more stable than Qdot 655Vivid in all
buffers, but especially in BKRA (Tukey pairwise comparisons with 95% CI; * p<0.05). D: Qdot 655Vivid
signal in Bond Wash and TBS quickly became undetectable due to quenching and photobleaching, but this
was significantly improved in BKRA (Bond Wash and TBS grouping separately to BKRA, using Tukey
pairwise comparisons with 95% CI; * p<0.05). E: Representative images of the quenching. All images were
taken 1270 min after the staining. 1st column: slides were mounted straight after the staining; 2nd to 4th
column: slides were mounted after 330 minutes in the indicated buffer. Fluorescence images are shown with
the same scale: 0–0.04 for Qdot 565; 0–0.18 for Qdot 655. The system is able to quantify intensity of
fluorescence ranging over at least 3 logs; however the requirement to show the fluorescence images with the
same scale means for comparison means some images may appear black, even though the quantification
was within the compatibility of the system.
doi:10.1371/journal.pone.0163856.g007
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original Qdots. This was achieved through “modification of the core/shell manufacture” with
“structural and compositional improvements to the semiconductor nanocrystal “while “the
polymer coating(s) remained unchanged” (LifeTechnology, personal communication). How-
ever the photostability of the Quantum dot is also related to the shell. Grabolle et al [17]
describedhow a thicker shell increases the stability of the Quantum dot but at the cost of
imperfections that reduce the radiation-less recombination and thus the quantum yield. They
suggested that a reliable shell can only provide a fluorescence quantum yield of about 50% and
that it is important to find a compromise between adequate particle stability and high quantum
yield. They describedhow some Quantum dots they tested had high quantum yield but low sta-
bility and called for a standardised quality control test for Quantum dots [17].
The present data show that Qdot 585Vivid is less stable than other Vivid Qdots, while
Qdots 705Vivid and 625Vivid are the most stable of the Vivid range in experimental conditions
relevant to tissue section immunofluorescence.Without detailed information about the chem-
istry of the Qdots we used it is difficult to speculate on the reasons for these differences, but it is
reassuring that we were able to find a protocol in which the fluorescence of all Vivid Qdots was
stable enough for reliable quantification of multiplex immunohistochemistry. Original Qdots
remain the most stable of the Qdots we have worked with, and we believe that it is possible to
obtain those as a custom order, although the excellent matched mounting media that was ini-
tially recommended is now unavailable.
There is a constant drive to optimise products and this is particularly true for Q-dots, which
exhibit excellent properties and have great potential in diverse applications [12, 20–24]. With
such diversity, vendors cannot pre-test all relevant user settings and this was highlighted by the
challenges we faced after the replacement of Qdots with Vivid Qdots. While all Qdots were
apparently stable under the vendor’s testing conditions, and also in our hands in short term
experiments (single staining), more challenging experimental conditions highlighted the inade-
quacy of the mounting media initially recommended, as well as the destabilising effect on the
fluorescence of various commonly used buffers (Table 3). Further alterations in Q-dot synthe-
sis are likely with developments in chemistry or production of the Q-dots [18, 22, 23, 25, 26]
and these will not necessarily be flagged to customers, as was the case for the Vivid technology.
Until a reliable and recognised quality standard is set that provides customers with confidence
about the reliability and reproducibility of the product in their application, researchers must
ensure that the parameters important to their study are checked and controlled. The risk is
greatest when researchers lacking experience in a particular area such as tissue histochemistry
or fluorescence imaging, turn to it for a particular focused application, relying on a “kit”
approach to the product, rather than more fundamental experience and controls to validate
their intended use.
Fluorescencemarkers are a mainstream tool in biological research and advances in detec-
tion and analysis technologies allow the detection of multiple targets in individual cells. The
complexity of multiplex immunofluorescence requires an optimised set-up that includes the
hardware, the imaging software and the assays to achieve and confirm specificity, sensitivity
and most importantly reproducibility. Even semi-quantitative evaluation requires optimisation
Fig 8. Example of stability of Qdots in different buffers in solution. A: Example of Qdot 565 & Qdot 655Vivid. Stability of
all the Qdots were tested in 96 well plates in the buffers and solutions used in our multiplex staining, as well as other common
buffers. Two dilutions of each Qdot were analysed in duplicate. B: The interval plot summarises (95%CI) the relative intensity
(with 95% confidence limits) for Qdot 565 and Qdot 655Vivid in the different buffers, showing that BKRA (DAKO background
reducing agent) provides the best stability. Intensity in all other buffers became significantly reduced for at least one Qdot
within 30–90 minutes (ANOVA with Dunnett comparison with t0 as control). Addition of Tween to either Tris or Borate buffer
further decreased fluorescence stability for all Qdots. All Qdots tested behaved similarly in solution (data not shown). SFB:
serum free block.
doi:10.1371/journal.pone.0163856.g008
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and control of all the parameters in the staining and imaging chain, including stability of the
staining. The choice of fluorophore is crucial and many dyes with different characteristics and
qualities are available and developed regularly [27, 28]. Four key characteristics of a suitable
fluorophore can be enumerated as: 1. Bright, so that low level target can be detected; this also
reduces the capture time and risk of photobleaching, so high extinction coefficient and quan-
tum yield are an advantage. 2. Narrow emission spectrumwith a large Stokes shift; this allows a
better and specific detection of the emission, without spectral overlap between fluorophores
(which filters only incompletely correct) and bleed through (cross-bleeding). 3. Excellent
photostability, as quantification cannot be achieved with a dye that photobleaches significantly
Fig 9. Reproducible stability of Qdot fluorescence in multiplex immunofluorescence. A: representative
images (about 1/8 of the actual captured images) of a 7 colors staining taken on the day of staining and on the
last day of image capturing of the experiment (day 4 for the example shown). The markers and Qdots used are
indicated on the left of the images. The fields were matched as closely as possible. The images shown are
intensity images spectrally unmixed with Nuance, at the same scale on first and last day of capturing. The top 2
images are combined images for all 6 makers, with false color as indicated under each marker. B: plot showing
the intensity of fluorescence on the initial (x-axis) versus the last (y-axis) day of capturing (day 4) (16 x20 fields;
intensity in counts/s). The linearity confirms the stability of the staining, (Pearson coefficient r = 0.095
p<0.001). C: Stability plot for the indicated Qdots used in 11 6-colour multiplex experiments. Data is expressed
as mean fluorescence intensities (counts/s) per microscope field, analysed initially (D0) and various days later.
All data were analysed by the same operator, using AxioVision and manual thresholding for a cell-specific
marker to define the cells of interest. The plots show correlations between the initial intensity and the final
intensity for 6 Qdots pooled from 11 different staining batches. The specific fluorescence intensity did not
change significantly with time (daily to 5 days after initial staining) compared with the initial measured intensity
for all Q dots taken together (Pearson coefficient “r” is indicated for each Qdot all with p<0.001).
doi:10.1371/journal.pone.0163856.g009
Table 2. Example of controls for a 5-marker multiplex immunofluorescence. Eleven serial sections of a control block are stained with the experimental
samples and serve as controls.
1 2 3 4 5 6 7 8 9 10 11
xxxxx xxxxx xxxxx xxxxx xxxxx xxxxx xxxxx xxxxx xxxxx xxxxx xxxxx
Marker 1 Marker 1 Marker 1 Marker 1 Marker 1 Marker 1 Marker 1 Marker 1 Marker 1 Marker 1
Goat
αMouse
GoatαMouse Goat
αMouse
Goat
αMouse
Goat
αMouse
Goat
αMouse
Goat
αMouse
Goat
αMouse
Goat
αMouse
Goat
αMouse
Goat
αMouse
Marker 2 Marker 2 Marker 2 Marker 2 Marker 2 Marker 2 Marker 2 Marker 2 Marker 2
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Marker 3 Marker 3 Marker 3 Marker 3 Marker 3 Marker 3 Marker 3 Marker 3
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Donkey
αMouse
Marker 4 Marker 4 Marker 4 Marker 4 Marker 4 Marker 4 Marker 4
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Donkey
αRabbit
Marker 5 Marker 5 Marker 5 Marker 5 Marker 5 Marker 5
αMouse
IgG3biot
αMouse
IgG3biot
αMouse
IgG3biot
αMouse
IgG3biot
αMouse
IgG3biot
αMouse
IgG3biot
αMouse
IgG3biot
5 markers
Qred
No primary
control
No primary
control
No primary
control
No primary
control
No primary
control
1 marker
no Qred
2 markers
no Qred
3 markers
no Qred
4 markers
no Qred
5 markers
no Qred
stability
Controls for crossbinding Controls for the loss of fluorescence during the full staining
process
For stability test, on day zero, 20 (x20 objective) to 40 fields (x40 objective) of slide 1 are imaged using Nuance. At regular intervals (at least once a day for
the time of the capturing), 4 fields are re-captured and the intensity of fluorescence for each marker is compared with day zero. The fields chosen are
changed every day to avoid potential confounding from photobleaching (which does not happen in our current experimental conditions). Comparisons of
slides 1 to 6 are used for cross binding control and 7 to 11 for quenching during the staining protocol.
doi:10.1371/journal.pone.0163856.t002
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under exposure. 4. No quenching from the local environment. Within commercially available
dyes, few, if any can match the performance of Qdots in terms of these criteria, including
extinction coefficient 10- to 500-fold greater and high quantum yields, with a fluorescence life
time 10–20 times longer than other organic fluorophores (30-100ns versus<5ns), together
generating a high signal to noise ratio [29]. The Qdot series spans the capture spectrum(emis-
sion peaks between 525 and 800nm) and has the advantage of a broad excitation, similar for all
Qdots, while large Stokes shifts and narrow symmetrical emission spectra eliminate spectral
overlap between absorption and emission. Their brightness allows labelling of low level target
without large non-linear amplification steps, cross-bleeding is minimal, and stability in the
present protocol is superior to many other fluorophores (Alexa dyes, FITC, TRITC are far less
photostable in our hands, although Cy3, Cy5 are photostable [5]. These features together maxi-
mise detection of fluorescencewithout interference, which makes quantificationmore reliable.
While still rather little used compared with less bright and apparently less stable fluorophores
such as Alexa dyes [30], Qdots with the present protocol are the fluorophore of choice for mul-
tiplex semi-quantitative or quantitative study.
Conclusion
In conclusion, with the present suggested protocol to maintain stability, we highly recommend
the use of Qdot fluorophores for multiplex immunofluorescence staining of tissue sections.We
also recommend that the photostability—whether quenching or bleaching—of each fluoro-
phore is controlled for during the staining process and after coverslipping until after image
capture. These validation data should be available with publication. We suggest some caution
when interpreting data published without such controls, particularly with newer purchased
Table 3. tested and recommended products for working with Qdots.
Original Vivid Notes
PBS Quenching Quenching avoid (even if manufacturer’s protocol still recommends all solutions in PBS)
TBS photobleaching Quenching & photobleaching avoid
Bond Wash photobleaching Quenching & photobleaching avoid
Tween @ 0.1% quenching quenching “stable up to 0.5% “in manufacturer information
avoid
BSA Provides some protection from quenching (in
Tris)
Test further if needed
Qdot diluant Good—Moderate quenching in solution Used in multiplex
Borate buffer Moderate quenching in solution Use with caution
TRIS quenching Use with caution to dilute BKRA if cost needs to be kept low
BKRA stable Used in multiplex
SFB Fairly stable Used in multiplex
Qdots
525 Stable Original Qdot–very stable and reliable in most buffer tested
565 Stable Original Qdot–very stable and reliable in most buffer tested
585V Least stable in all buffer tested including BKRA Avoid if possible Control for stability at all times
605V Average stability Control for stability at all times
625V Good stability Control for stability
655V Average stability Control for stability at all times
705V Good stability overall Control for stability
Cytoseal Good stability for 1 to 2 weeks Control for loss of fluorescence with time if quantitative analysis over more than 1 day
Ecomount Good stability for at least 2 weeks recommended
doi:10.1371/journal.pone.0163856.t003
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Qdots evaluated under the commonly used conditions shown here to promote instability, of
which experimenters would likely have been unaware and not tested.
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